Literature DB >> 27303208

Toxic Epidermal Necrolysis Induced by the Topical Carbonic Anhydrase Inhibitors Brinzolamide and Dorzolamide.

Ji Sun Chun1, Sook Jung Yun1, Jee Bum Lee1, Seong Jin Kim1, Young Ho Won1, Seung Chul Lee1.   

Abstract

Brinzolamide and dorzolamide are highly specific topical carbonic anhydrase inhibitors (CAIs). They lower intraocular pressure (IOP) by reducing the rate of aqueous humour formation without serious side effects. Although systemic CAIs are the most potent medications for lowering intraocular pressure for conditions with ocular hypertension, many cases with adverse systemic reactions have been reported, including Stevens-Johnson syndrome (SJS) and Toxic epidermal necrolysis (TEN). Here, we report 2 cases of TEN that were associated with topical CAIs rather than systemic CAIs.

Entities:  

Keywords:  Brinzolamide; Dorzolamide; Toxic epidermal necrolysis

Year:  2008        PMID: 27303208      PMCID: PMC4903995          DOI: 10.5021/ad.2008.20.4.260

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  7 in total

Review 1.  Update on topical carbonic anhydrase inhibitors.

Authors:  U Herkel; N Pfeiffer
Journal:  Curr Opin Ophthalmol       Date:  2001-04       Impact factor: 3.761

2.  Toxic epidermal necrolysis secondary to timolol, dorzolamide, and latanoprost eyedrops.

Authors:  Angeles Flórez; Elena Rosón; Alberto Conde; Beatriz González; Ignacio García-Doval; Carlos de la Torre; Manuel Cruces
Journal:  J Am Acad Dermatol       Date:  2005-11       Impact factor: 11.527

3.  Fumigant-induced toxic epidermal necrolysis.

Authors:  G F Radimer; J H Davis; A B Ackerman
Journal:  Arch Dermatol       Date:  1974-07

4.  A case of contact dermatitis, erythema multiforme, and toxic epidermal necrolysis.

Authors:  J A Thompson; B A Wansker
Journal:  J Am Acad Dermatol       Date:  1981-12       Impact factor: 11.527

Review 5.  Preclinical overview of brinzolamide.

Authors:  L DeSantis
Journal:  Surv Ophthalmol       Date:  2000-01       Impact factor: 6.048

Review 6.  Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension.

Authors:  Risto S Cvetkovic; Caroline M Perry
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 7.  The development of topically acting carbonic anhydrase inhibitors as anti-glaucoma agents.

Authors:  Francesco Mincione; Andrea Scozzafava; Claudiu T Supuran
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

  7 in total
  1 in total

1.  Do topical ocular antihypertensives affect Dacryocystorhinostomy outcomes: The Coventry experience.

Authors:  Priyanka Mandal; Harpreet Ahluwalia
Journal:  Eye (Lond)       Date:  2021-02-26       Impact factor: 3.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.